SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-18-004597
Filing Date
2018-11-16
Accepted
2018-11-16 19:16:30
Documents
2
Period of Report
2018-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 7995
2 BARCLAY PHILLIPS POA SEP 2018 pbarclaypoa_sep2018.txt EX-24 3409
  Complete submission text file 0001562180-18-004597.txt   12929
Mailing Address C/O CANCER VAX CORP 2110 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address
PHILLIPS BARCLAY A (Reporting) CIK: 0001265801 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 181191006

Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences